Anatara Lifesciences Ltd (ASX:ANR)
0.0090
0.00 (0.00%)
At close: Apr 27, 2026
Anatara Lifesciences Market Cap
Anatara Lifesciences has a market cap or net worth of 2.84 million as of April 29, 2026. Its market cap has decreased by -75.43% in one year.
Market Cap
2.84M
Enterprise Value
1.76M
Revenue
623.76K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since October 16, 2014, Anatara Lifesciences's market cap has decreased from 9.98M to 2.84M, a decrease of -71.49%. That is a compound annual growth rate of -10.31%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrux | 4.52M |
| Nexalis Therapeutics | 5.31M |
| Zelira Therapeutics | 5.95M |
| Chimeric Therapeutics | 6.63M |
| Vectus Biosystems | 7.21M |
| Invex Therapeutics | 7.52M |
| Biotron | 8.11M |
| Tissue Repair | 9.37M |